相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage
Sheetal Hardikar et al.
CANCER CAUSES & CONTROL (2014)
C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study
Laure Dossus et al.
CANCER CAUSES & CONTROL (2014)
Association Between Prediagnostic Biomarkers of Inflammation and Endothelial Function and Cancer Risk: A Nested Case-Control Study
Mathilde Touvier et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
A Prospective Study of Circulating C-Reactive Protein, Interleukin-6, and Tumor Necrosis Factor Receptor 2 Levels and Risk of Ovarian Cancer
Elizabeth M. Poole et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Association between sex hormones, glucose homeostasis, adipokines, and inflammatory markers and mammographic density among postmenopausal women
Christy G. Woolcott et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study
Anna E. Prizment et al.
CANCER CAUSES & CONTROL (2013)
Prediagnostic Leptin, Adiponectin, C-Reactive Protein, and the Risk of Postmenopausal Breast Cancer
Nicholas J. Ollberding et al.
CANCER PREVENTION RESEARCH (2013)
Trajectory Clustering of Estradiol and Follicle-Stimulating Hormone during the Menopausal Transition among Women in the Study of Women's Health across the Nation (SWAN)
Ping G. Tepper et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating levels of inflammatory markers and mammographic density among postmenopausal women
Katherine W. Reeves et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Association between Levels of C-Reactive Protein and Leukocytes and Cancer: Three Repeated Measurements in the Swedish AMORIS Study
Mieke Van Hemelrijck et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer
Kristine H. Allin et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2011)
Oral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomes
Emily G. Kurtz et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2011)
Physical Activity and Change in Mammographic Density
Shannon M. Conroy et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study
Laure Dossus et al.
ENDOCRINE-RELATED CANCER (2010)
Lactation and Incidence of Premenopausal Breast Cancer A Longitudinal Study
Alison M. Stuebe et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis
Katriina Heikkilae et al.
CANCER CAUSES & CONTROL (2009)
C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy)
Eva Lundin et al.
CANCER CAUSES & CONTROL (2009)
Adipokines, Inflammation, and Visceral Adiposity across the Menopausal Transition: A Prospective Study
Christine G. Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Association between C-Reactive Protein and Adiposity in Women
Murielle Bochud et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer
Kristine H. Allin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
C-reactive protein and coronary heart disease: a critical review
J. P. Casas et al.
JOURNAL OF INTERNAL MEDICINE (2008)
Re: C-reactive protein and risk of breast cancer
Anne Zeleniuch-Jacquotte et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN)
Lesley M. Butler et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Mammographic density - Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence
Lisa J. Martin et al.
BREAST CANCER RESEARCH (2008)
A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project
H. G. Burger et al.
HUMAN REPRODUCTION UPDATE (2007)
Mammographic density in a multiethnic cohort
Laurel A. Habel et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2007)
C-reactive protein and risk of breast cancer
Shumin M. Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
A systematic review of the association between circulating concentrations of C reactive protein and cancer
Katriina Heikkila et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2007)
C-reactive protein levels, variation in the c-reactive protein gene, and cancer risk: The Rotterdam Study
Claire Siemes et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Body size, mammographic density, and breast cancer risk
Norman F. Boyd et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis
Gillian K. Reeves et al.
LANCET ONCOLOGY (2006)
Breast density and parenchymal patterns as markers of breast cancer risk: A meta-analysis
Valerie A. McCormack et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
A longitudinal investigation of mammographic density: The multiethnic cohort
G Maskarinec et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Plasma C-reactive protein and risk of cancer: A prospective study from Greece
D Trichopoulos et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Postmenopausal serum androgens, oestrogens and breast cancer risk:: the European prospective investigation into cancer and nutrition
R Kaaks et al.
ENDOCRINE-RELATED CANCER (2005)
Hemostatic factors and estrogen during the menopausal transition
MR Sowers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Measurements of breast density: No ratio for a ratio
G Haars et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort
D Il'yasova et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative Randomized Trial
A McTiernan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein - A randomized placebo-controlled study
P Bogaty et al.
CIRCULATION (2004)
C-reactive protein
S Black et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
TA Pearson et al.
CIRCULATION (2003)
Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention
G Davies et al.
ANNALS OF ONCOLOGY (2002)
Genetic determinants of mammographic density
CA Haiman et al.
BREAST CANCER RESEARCH (2002)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy
CM Rutter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Growth differentiation factor-9 stimulates progesterone synthesis in granulosa cells via a prostaglandin E2/EP2 receptor pathway
JA Elvin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Evaluation of the Kaiser Physical Activity Survey in women
BE Ainsworth et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2000)
分享论文
